MAGI2‐AS3 also exerts effects on the biological activities of hepatic cancer cells (Jiang et al., 2016), but the effects and mechanisms of MAGI2‐AS3 in HCC treatment are still unclear. This evidence concerns the gene PDS5B and hepatocellular carcinoma.